- ongoing, recruitingTherapeutic exploratory (Phase II)
Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct)
This study is testing a new medicine called bemcentinib for people with moderate COVID-19. It aims to see if the medicine can help them get better faster and prevent them from becoming more unwell. Researchers will also check if the medicine is safe to use.
Greece · Luxembourg · Czechia - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A trial to learn if different doses of REGN17092 are safe in healthy adults
This study is looking at a new medicine called REGN17092 to see if different doses are safe for healthy adults. It's an early-stage trial trying to understand if the medicine could help with COVID-19. Participants will be carefully checked throughout the study.
Belgium